Bipolar Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1183
|
839
|
0.680 |
None |
1.000 |
10 |
2
|
2011 |
2019 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.350 |
None |
1.000 |
5 |
1
|
2011 |
2015 |
CUI: |
C0338831 |
Disease: |
Manic
|
Manic
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
166
|
8
|
0.310 |
None |
1.000 |
2 |
|
2012 |
2019 |
Depression, Bipolar
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
116
|
2
|
0.300 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant neoplasm of urinary bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2113
|
316
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Bladder Neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2130
|
281
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Manic Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
76
|
|
0.300 |
None |
1.000 |
1 |
|
2019 |
2019 |
Non-alcoholic Fatty Liver Disease
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1058
|
222
|
0.180 |
None |
0.875 |
8 |
1
|
2011 |
2019 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
5 |
2
|
2012 |
2019 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
4 |
2
|
2009 |
2019 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
4 |
3
|
2012 |
2019 |
Serum HDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
283
|
679
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
C-reactive protein measurement
|
phenotype |
|
Laboratory Procedure
|
135
|
624
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Depressed bipolar I disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
37
|
59
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Serum LDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
269
|
555
|
0.100 |
None |
1.000 |
1 |
3
|
2012 |
2012 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Steatohepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1143
|
75
|
0.020 |
None |
1.000 |
2 |
1
|
2013 |
2015 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.020 |
None |
1.000 |
2 |
1
|
2014 |
2019 |
Deafness, Sudden
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Sign or Symptom
|
6
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Childhood Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2420
|
231
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
(Idiopathic) normal pressure hydrocephalus
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Renal Insufficiency
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
615
|
42
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Developmental reading disorder
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
33
|
32
|
0.010 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Major Depressive Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1236
|
1451
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Neuropathy
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
484
|
110
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |